Retroperitoneal laparoscopic radical nephrectomy: Intermediate oncological results

被引:12
作者
Larre, Stephane [1 ,2 ]
Kanso, Chaker [2 ]
De La Taille, Alexandre [2 ]
Hoznek, Andras [2 ]
Vordos, Dimitrios [2 ]
Yiou, Rene [2 ]
Abbou, Clement-Claude [2 ]
Salomon, Laurent [2 ]
机构
[1] Univ Sheffield, Royal Hallamshire Hosp, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England
[2] Henri Mondor Univ Hosp, Dept Urol, Creteil, France
关键词
Kidney neoplasms; Laparoscopy; Nephrectomy; Retroperitoneal space; Survival;
D O I
10.1007/s00345-008-0306-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
To report the intermediate oncological results of laparoscopic radical nephrectomy by retroperitoneal approach. From 1995 to 2006, 146 consecutive patients with removal of a malignant kidney tumor by laparoscopic retroperitoneal radical nephrectomy were analysed retrospectively. The patients were followed clinically, biologically and radiologically every 6 months. Disease-free survival and specific survival were determined among patients free of metastasis at surgery. Patient's average age was 61.1 years (25-85). The pathology of these cancers were: 108 clear cell carcinomas, 26 papillary carcinomas, 10 chromophobe carcinomas, and 2 miscellaneous. The T stage were: 105 pT1, 12 pT2, and 29 pT3 (TNM 2002). The Fuhrman grade were: I in 23 cases, II in 70 cases, III in 40 cases, and IV in 9 cases. The surgical margins were positive in 2. No port site recurrence occurred. The average follow-up was 35.4 months (1-137). Five patients had metastatic disease at presentation. Tumor progression was observed among 19 patients, in the form of a local (1) or remote recurrence (18). Fourteen patients died, including 7 because of their tumor. The disease-free survival at 5 and 10 years, were respectively 87.3 and 73.2%, and the cancer-specific survival were 96.2 and 92.0%, respectively. The laparoscopic retroperitoneal radical nephrectomy offers intermediate oncological results compatible with appropriate carcinological efficacy.
引用
收藏
页码:611 / 615
页数:5
相关论文
共 24 条
[1]
Retroperitoneal laparoscopic versus open radical nephrectomy [J].
Abbou, CC ;
Cicco, A ;
Gasman, D ;
Hoznek, A ;
Antiphon, P ;
Chopin, DK ;
Salomon, L .
JOURNAL OF UROLOGY, 1999, 161 (06) :1776-1780
[2]
Laparoscopic radical nephrectomy: Cancer control for renal cell carcinoma [J].
Chan, DY ;
Cadeddu, JA ;
Jarrett, TW ;
Marshall, FF ;
Kavoussi, LR .
JOURNAL OF UROLOGY, 2001, 166 (06) :2095-2099
[3]
Carcinological risks and retroperitoneal laparoscopy [J].
Cicco, A ;
Salomon, L ;
Hoznek, H ;
Alame, W ;
Saint, F ;
Bralet, MP ;
Antiphon, P ;
Chopin, DK ;
Abbou, CC .
EUROPEAN UROLOGY, 2000, 38 (05) :606-612
[4]
Results of retroperitoneal laparoscopic radical nephrectomy [J].
Cicco, A ;
Salomon, L ;
Hoznek, A ;
Saint, F ;
Alame, W ;
Gasman, D ;
Antiphon, P ;
Chopin, DK ;
Abbou, CC .
JOURNAL OF ENDOUROLOGY, 2001, 15 (04) :355-359
[5]
CLAVIEN PA, 1992, SURGERY, V111, P518
[6]
LAPAROSCOPIC NEPHRECTOMY - INITIAL CASE-REPORT [J].
CLAYMAN, RV ;
KAVOUSSI, LR ;
SOPER, NJ ;
DIERKS, SM ;
MERETYK, S ;
DARCY, MD ;
ROEMER, FD ;
PINGLETON, ED ;
THOMSON, PG ;
LONG, SR .
JOURNAL OF UROLOGY, 1991, 146 (02) :278-282
[7]
Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy [J].
Desal, MM ;
Strzempkowski, B ;
Matin, SF ;
Steinberg, AP ;
Ng, C ;
Meraney, AM ;
Kaouk, JH ;
Gill, IS .
JOURNAL OF UROLOGY, 2005, 173 (01) :38-41
[8]
Retroperitoneoscopic versus open surgical radical nephrectomy for large renal cell carcinoma in clinical stage cT2 or cT3a: Quality of life, pain and reconvalescence [J].
Dillenburg, W ;
Poulakis, V ;
Skriapas, K ;
de Vries, R ;
Ferakis, N ;
Witzsch, U ;
Melekos, M ;
Becht, E .
EUROPEAN UROLOGY, 2006, 49 (02) :314-323
[9]
Laparoscopic versus open radical nephrectomy: A 9-year experience [J].
Dunn, MD ;
Portis, AJ ;
Shalhav, AL ;
Elbahnasy, AM ;
Heidorn, C ;
McDougall, EM ;
Clayman, RV .
JOURNAL OF UROLOGY, 2000, 164 (04) :1153-1159
[10]
Application of tnm, 2002 version, in localized renal cell carcinoma: Is it able to predict different cancer-specific survival probability? [J].
Ficarra, V ;
Novara, G ;
Galfano, A ;
Novella, G ;
Schiavone, D ;
Artibani, W .
UROLOGY, 2004, 63 (06) :1050-1054